Buscar
01/07/2024
Evaluation of effective left ventricular pacing in cardiac resynchronization therapy
Zurita, FFM, Santos, JQ, Font, ER, Martin, CA, Ramos, JG, Garcia, BC, Weidmann, ZM, Bravo, EG, De Diego, IR, Martin, LS, Osorio, MG, Ramirez, DM, Jaen, EP, Nieves, AV, Prat, XV. Evaluation of effective left ventricular pacing in cardiac resynchronization therapy. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).
01/07/2024
Ability of antigen carbohydrate 125 for diagnosis of heart failure with preserved ejection fraction
Baguda, JJD, Villota, JN, De la Espriella, R, De la Cal, TS, Vega, DG, Perez, PC, Carmena, MDGC, Minana, G, Sousa, I, Santas, E, Dolz, LM, Ferrer, MD, Gonzalez-Juanatey, JR, Martinez-Selles, M, Jimenez, JFD. Ability of antigen carbohydrate 125 for diagnosis of heart failure with preserved ejection fraction. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).
01/07/2024
Rationale and design of a randomized double-blind trial to study the benefit of colchicine in patients with acutely decompensated heart failure: COLICA trial.
Villa, NF, Perez-Martinez, MT, Garcia-Garcia, AM, Nunez-Villota, J, Gonzalez-Juanatey, JR, Taibo-Urquia, M, Delgado-Jimenez, J, Bayes-Genis, A, Llacer-Iborra, P, Mirabet-Perez, S, Martinez-Selles, M, Anguita-Sanchez, M, Aimo, A, Sanchez-Fernandez, PL, Pascual-Figal, DA. Rationale and design of a randomized double-blind trial to study the benefit of colchicine in patients with acutely decompensated heart failure: COLICA trial.. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).
01/07/2024
Particularities of foundational therapy in patients with newly diagnosed heart failure and reduced LVEF secondary to tachycardiomyopathy
Fernandez, AAE, Otero, IG, Fernandez, SL, Santamarta, MR, Brugues, PF, Perez, FP, Corral, ES, Lopez, AL, Pinilla, JMG, Palomas, JLB, Bonet, LA, Marcos, MC, Mateo, VM, Benedicto, AM, Baguda, JD. Particularities of foundational therapy in patients with newly diagnosed heart failure and reduced LVEF secondary to tachycardiomyopathy. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).
01/07/2024
Impact of preoperative left ventricular unloading on post-transplant outcomes of candidates bridged with venoarterial extracorporeal membrane oxygenation
Vazquez, DE, Barge-Caballero, E, Gonzalez-Vilchez, F, Almenar-Bonet, L, Garcia-Cosio, MD, Gonzalez-Costello, J, Gomez-Bueno, M, Castel-Lavilla, MA, Diaz-Molina, B, Martinez-Selles, M, Mirabet-Perez, S, De La Fuente-Galan, L, Hervas-Sotomayor, D, Rangel-Sousa, D, Crespo-Leiro, M. Impact of preoperative left ventricular unloading on post-transplant outcomes of candidates bridged with venoarterial extracorporeal membrane oxygenation. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).
01/07/2024
Embolization of percutaneous left atrial appendage closure devices: Timing, management and clinical outcomes
Eppinger, S, Piayda, K, Galea, R, Sandri, M, Maarse, M, Güner, A, Karabay, CY, Pershad, A, Ding, WY, Aminian, A, Akin, I, Davtyan, KV, Chugunov, IA, Marijon, E, Rosseel, L, Schmidt, TR, Amabile, N, Korsholm, K, Lund, J, Guerios, E, Amat-Santos, IJ, Boccuzzi, G, Ellis, CR, Sabbag, A, Ebelt, H, Clapp, B, Assa, HV, Levi, A, Ledwoch, J, Lehmann, S, Lee, OH, Mark, G, Schell, W, della Rocca, DG, Natale, A, de Backer, O, Kefer, J, Esteban, PP, Abelson, M, Ram, P, Moceri, P, Osuna, JGG, Alvarez, XM, Cruz-Gonzalez, I, de Potter, T, Ghassan, M, Osadchiy, A, Chen, W, Goyal, SK, Giannini, F, Rivero-Ayerza, M, Afzal, S, Jung, C, Skurk, C, Langel, M, Spence, M, Merkulov, E, Lempereur, M, Shin, SY, Mesnier, J, Mckinney, HL, Schuler, BT, Armero, S, Gheorghe, L, Ancona, MBM, Santos, L, Mansourati, J, Nombela-Franco, L, Nappi, F, Kühne, M, Gaspardone, A, van der Pals, J, Montorfano, M, Fernández-Armenta, J, Harvey, JE, Rodés-Cabau, J, Klein, N, Sabir, SA, Kim, JS, Cook, S, Kornowski, R, Saraste, A, Nielsen-Kudsk, JE, Gupta, D, Boersma, L, Räber, L, Sievert, K, Sievert, H, Bertog, S. Embolization of percutaneous left atrial appendage closure devices: Timing, management and clinical outcomes. Cardiovascular Revascularization Medicine. 2024; 64DOI:10.1016/j.carrev.2024.02.014. PMID:38448258. IF:(Q/D).
01/07/2024
The Influence of Metabolic Risk Factors on the Inflammatory Response Triggered by Myocardial Infarction: Bridging Pathophysiology to Treatment
Ramos-Regalado, L, Alcover, S, Badimon, L, Vilahur, G. The Influence of Metabolic Risk Factors on the Inflammatory Response Triggered by Myocardial Infarction: Bridging Pathophysiology to Treatment. Cells. 2024; 13(13)DOI:10.3390/cells13131125. PMID:38994977. IF:5.200(Q2/3D).
01/07/2024
Temporal trends in ICD prescription as primary prevention in non ischemic cardiomyopathy: 10 year single center registry
Crehuet, A, Abos, CM, Corcoy, MSI, Donlo, JM, Garcia, BC, Iniesta, MS, Ramon, CS, Benedicto, AM, Varo, AP, Ferrer, MD, Crespo, MC. Temporal trends in ICD prescription as primary prevention in non ischemic cardiomyopathy: 10 year single center registry. EUROPEAN JOURNAL OF HEART FAILURE. 2024; 26DOI:. PMID:. IF:10.800(Q1/1D).